Attorney/Pharm.D/Certified Pharmacy Benefits Specialist. Shareholder @ Buchanan Ingersoll Rooney
Fort Lee, NJ
Joined September 2019
- Tweets414
- Following314
- Followers248
- Likes626
Dae Y. Lee retweeted
PBMs say they are highly pass-through if you take out:
💸 GPO fees
💸 340B spreads
💸 drugmaker fees
💸 rebate exclusions
💸 effective rate spreads
💸 clawbacks
💸 transaction fees
💸 audit takebacks
💸 prior authorization fees
💸 specialty pharmacy markups
💸 integration fees
Dae Y. Lee retweeted
🚨 Congress has cleared the funding bill containing several NCPA priority PBM reform provisions, and it's off to President Trump for signature! bit.ly/4tgkKW6
Dae Y. Lee retweeted
#FrierLevitt attorneys are featured in a @SpecialtyPharm article, "A War Brewing Between GLP-1 Manufacturers and Compounders," highlighting Novo Nordisk's request that the FDA add Wegovy products to the DDC List.
Learn more here: frierlevitt.com/news/dae-lee…
Dae Y. Lee retweeted
Join Our Upcoming Webinar - BOPs and PBMs in Focus: Navigating Industry Changes for 2024-2025
📆 Date: November 19, 2024
⏰ Time: 12:30-1:30 PM ET
Who should attend? Pharmacists, pharmacy owners, pharmacy technicians, and wholesalers.
Sign up here: frierlevitt.com/event/bops-a…
Dae Y. Lee retweeted
Independent pharmacies nationwide are experiencing a troubling trend, as PDMI has been terminating them from GLP-1 manufacturers’ coupon programs without explanation.
Read #FrierLevitt article to learn more: frierlevitt.com/articles/glp…
Dae Y. Lee retweeted
#FrierLevitt successfully reduced a multi-million-dollar rebate demand by a #PBM and its rebate aggregator against a drug manufacturer client by 83%.
Read the article to learn more: frierlevitt.com/news/frier-l…
Dae Y. Lee retweeted
The #FDA's removal of #tirzepatide from its drug shortage list has sparked legal action and presents immediate challenges for 503B outsourcing facilities and compounding pharmacies.
Read #FrierLevitt article to learn more: frierlevitt.com/articles/fda…
Dae Y. Lee retweeted
Don't forget to register for next week's @scriptainsights webinar, "Know Your Fiduciary Duty in Rx Benefits" with #FrierLevitt attorneys Dae Y. Lee and Adam Farkas!
📆 Thursday, September 19, 2024 | 2:00 p.m. ET
Reserve your spot below 👇
us02web.zoom.us/webinar/regi…
Dae Y. Lee retweeted
📣 Upcoming Webinar
Join us for "Mastering GLP-1 Compounding Series Q&A Roundup," where we'll dive into the most pressing questions from our recent GLP-1 Compounding Series.
🕓 Thursday, September 12, 2024 | 2:00-3:00 PM ET
Register here: frierlevitt.com/event/master…
#FrierLevitt
Dae Y. Lee retweeted
On this Labor Day, we honor the resilience and dedication of workers in every industry, with special thanks to our team at Frier Levitt for their commitment to excellence.
Have a safe and happy Labor Day!
#LaborDay #FrierLevitt #HealthcareLaw #PharmacyLaw
Dae Y. Lee retweeted
📣 Is your pharmacy prepared for a PBM audit?
At #FrierLevitt, we know first-hand the importance of being audit-ready. That's why we've developed a comprehensive #PBM Audit Checklist to help you navigate the process seamlessly.
Download here: frierlevitt.com/pbm-audit-ch…
Dae Y. Lee retweeted
📢 Our attorneys' insights were featured in a Drug Topics article on the $45M CVS Caremark settlement with the State of Illinois. This landmark case highlights the critical need for transparency in PBM operations. #PBMTransparency #FrierLevitt
Read more: frierlevitt.com/news/frier-l…
Dae Y. Lee retweeted
Beneficiaries of Wells Fargo’s prescription drug benefit plan have filed an #ERISA class action lawsuit against the bank, following a similar case against Johnson & Johnson.
Read #FrierLevitt article to learn more: frierlevitt.com/articles/wel…
#PlanSponsors #PBMs #JNJ #WellsFargo
Dae Y. Lee retweeted
The #DOJ announced a $101 million settlement with Rite Aid Corporation and its subsidiaries for #FalseClaimsAct violations involving fraudulent rebate retention.
Read #FrierLevitt article to learn more: frierlevitt.com/articles/rit…
#PBMs #Rebates
Dae Y. Lee retweeted
The Federal Trade Commission (FTC) continues to investigate PBMs and their impact on prescription drug costs and availability. Recently, the #FTC issued an interim report addressing drug manufacturer rebates.
Read #FrierLevitt article to learn more: frierlevitt.com/articles/fed…
Dae Y. Lee retweeted
#FrierLevitt co-founding partner Jonathan Levitt quoted in a @bloomberglaw article discussing the increasing lawsuits against employers and health insurers for not managing health plan costs effectively.
Read more here: frierlevitt.com/news/jonatha…
Dae Y. Lee retweeted
Impact on Independent Pharmacies:
FTC finds that PBMs exert substantial influence over independent pharmacies, who struggle with contract terms they find confusing, unfair, and harmful.
#FTCreport #IndependentPharmacies #VerticalIntegration
Dae Y. Lee retweeted
In a recent victory, #FrierLevitt attorneys successfully aided a NJ pharmacy overturned more than 91% of the alleged discrepancies issued by a major #PBM.
Read our latest article to learn more: frierlevitt.com/news/frier-l…
Dae Y. Lee retweeted
#FrierLevitt partner Dae Y. Lee is featured on The Bottom Line Pharmacy Podcast by @SykesCompanyPA in an episode titled, “Navigating The Legal Maze of 503B Compounding.”
Visit our website to watch the podcast: frierlevitt.com/news/dae-y-l…
#PBMs #Semaglutide
Dae Y. Lee retweeted
Learn to navigate the unique regulatory challenges of GLP-1 #CompoundingPharmacies at #FrierLevitt’s 3-part webinar starting June 13. Part 1 covers FDA regulations for 503A & 503B #PharmaceuticalCompounding, state laws, and more. Register: bit.ly/4aWvYEE
#HealthcareLaw
